BioSpace News Archive

Cardinal Health plans to release second-quarter financial results for its fiscal year 2019 on February 7 prior to the opening of trading on the New York Stock Exchange.

Kindred Biosciences, Inc. today announced positive topline results from its pilot field effectiveness study of epoCat (KIND-510a), a long-acting feline recombinant erythropoietin that is being developed for the management of anemia in cats.

TransMedia said Dr. Dara, known for her productive marathon sessions in South Florida, believes she has a prescription for ending the deadlock over President Trump’s wall

Presentations Showcase the Importance of Treating Post-Angioplasty Dissections

AmorChem II is proud to announce the closing of its first financing of a university project.

Broadening OMIDRIA Coverage from Payers and Increasing Funding for OMS721 Commercial Preparations

Astellas Pharma Canada, Inc., today announced that Health Canada approved an expanded indication for enzalutamide, an androgen receptor inhibitor for the treatment of patients with prostate cancer, following a Priority Review by Health Canada’s Therapeutic Products Directorate (TPD).

S&P Global Market Intelligence announced today the introduction of new alternative data set through its data feed management system, Xpressfeed™. This pharmaceutical package is a curated, sector-specific data feed which maps Panjiva supply chain data to the Food and Drug Administration’s (FDA) Orange Book.

The expanded 66,000 square foot Cancer Center was designed to provide space for the hospital’s growth and to enhance the facility’s cancer research and treatment facilities.

Curere is a patented, regenerative skin care line created to treat a range of skin conditions, including acne, third-degree burns and necrosis.